CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.

Kim Margolin; Jeffrey Longmate; Tracey Baratta; Tim Synold; Scott Christensen; Jeffrey Weber; Thomas Gajewski; Ian Quirt; James H Doroshow

doi:10.1002/cncr.21265

CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.

Identifier:nobleid.org/w1/20260515/FC949323

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FC949323.svg?ark=w1%2F20260515%2FFC949323)](https://nobleid.org/work/w1/20260515/FC949323)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.

Identifier:nobleid.org/w1/20260515/FC949323

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FC949323.svg?ark=w1%2F20260515%2FFC949323)](https://nobleid.org/work/w1/20260515/FC949323)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work